The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-ac...
Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & D...
Genentech, a Roche’s subsidiary announced that the US Food and Drug Administration (FDA) has approved Rozlytrek&tr...
Certara®, the global model-informed drug development and decision support leader, on 30 July 2019, announced the lau...
Bayer AG and BlueRock Therapeutics hasannounced an agreement under which Bayer will fully acquire BlueRock Therapeutics,...
Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for ...
Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough...
3SBio Inc., a leading biopharmaceutical company in the People's Republic of China (PRC) has announced that an applicatio...
AstraZeneca has announced that data from two Phase III trials evaluating the efficacy and safety of roxadustat in China....
Japan headquartered Sosei Group Corporation has entered into a multi-target research collaboration and license agreement...
Japanese pharmaceutical firm Eisai Co.,Ltd. has announced that it has entered into a collaboration research agreement wi...
CEL-SCI Corporation (NYSE American: CVM) announced that one of its key collaborators from Rush University Medi...
Gilead Sciences, Inc., on 24 June 2019, announced that the Singapore Health Sciences Authority (HAS) has approved Vosevi...
Gilead Sciences and Nurix Therapeutics, Inc., have announced a global strategic collaboration to discover, dev...
Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the ...
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...
Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...
CStone Pharmaceuticals, on 9 June 2019, announced its global clinical collaboration with China focus with Baye...
